Hepregen

How does the HepatoPac™ platform compare to conventional in vitro methods for liver metabolism and toxicity testing? Download this informative white paper
to see how HepatoPac™ can benefit you.

Get the latest on the microliver platform
that’s transforming metabolism and toxicity testing

Everyone’s talking about HepatoPac™, the novel microliver platform that offers a whole new direction in liver metabolism and toxicity testing. HepatoPac’s long-term stability of 4-6 weeks allows in vivo-level predictability in an in vitro format, giving you an innovative yet practical method to better prioritize and select compounds-so you can reduce your attrition rate.

Join the conversation. Simply click on a link below to register for an event,
or download our latest white paper.

Upcoming Events

• FEB

  15

  February 15-17, 2012

  4th Annual Predictive Toxicology

  Hepregen Corporation will be exhibiting at this event. Dr. Okechukwu Ukairo, Senior Principal Scientist, ADME/Tox Services, will be speaking Thursday, February 16, 2012 at 10:45 am on "A Novel Micropatterned Hepatocyte Co-culture System for Drug Metabolism and Toxicity Studies".

• MAR

  11

  March 11-15, 2012

  Society of Toxicology Annual Meeting and ToxExpo

  Hepregen Corporation will be exhibiting at this event hosted at the Moscone Convention Center. Stop by Booth #2336. Dr. Okechukwu Ukairo, Senior Principal Scientist, ADME/Tox Services, will be speaking Monday, March 12, 2012 at 9:15 am in Room 105 on "The Use of Human HepatoPac™, an In Vitro Microliver Platform, for Predictive Toxicology ".

• MAR

  27

  March 27-29, 2012

  3rd Annual World PK/PD Summit

  Hepregen Corporation will be a sponsor for this event hosted at the DoubleTree Suites by Hilton in Boston, MA. Hepregen will also be exhibiting.